Outcomes of prostate cancer screening among men using antidiabetic medication

Outcomes of prostate cancer screening among men using antidiabetic medication

Abstract Diabetic men have decreased risk for prostate cancer (PCa) overall and lower PSA compared to non-diabetics. This may affect the outcomes of PSA-based screening. We investigated the effect of PSA-based screening at 4-year intervals on PCa incidence and mortality separately among users and no...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: A. Vettenranta, T. J. Murtola, K. Talala, K. Taari, U.-H. Stenman, T. L. J. Tammela, A. Auvinen
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
Medicine
R
Science
Q
Acceso en línea:https://doaj.org/article/4c87bb3f20a146979b5d700888507321
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

Ejemplares similares